New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For VVUS;TSN;DELL;ALKS;MCK;GDOT;MRK;LTM;NFLX;CTRP;ADNC;ELN;MAT From The Last 14 Days
Check below for free stories on VVUS;TSN;DELL;ALKS;MCK;GDOT;MRK;LTM;NFLX;CTRP;ADNC;ELN;MAT the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | all recent news | >>
April 7, 2014
16:01 EDTNFLXOptions Update; April 7, 2014
Subscribe for More Information
10:00 EDTMATOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
10:00 EDTNFLXOn The Fly: Analyst Upgrade Summary
Agios Pharmaceuticals (AGIO) upgraded to Overweight from Neutral at JPMorgan... Alcoa (AA) upgraded to Hold from Sell at Deutsche Bank... Align Technology (ALGN) upgraded to Outperform from Market Perform at Barrington... Analog Devices (ADI) upgraded to Neutral from Sell at Goldman... B&G Foods (BGS) upgraded to Outperform from Sector Perform at RBC Capital... Citigroup (C) upgraded to Neutral from Underweight at HSBC... Intel (INTC) upgraded to Outperform from Sector Perform at Pacific Crest... JetBlue (JBLU) upgraded to Neutral from Sell at Goldman... Kindred Healthcare (KND) upgraded to Outperform from Sector Perform at RBC Capital... Lennox (LII) upgraded to Outperform from Market Perform at Wells Fargo... Newmont Mining (NEM) upgraded to Hold from Sell at Deutsche Bank... PBF Energy (PBF) upgraded to Buy from Neutral at Citigroup... Renasant (RNST) upgraded to Outperform from Market Perform at Raymond James... Select Medical (SEM) upgraded to Outperform from Sector Perform at RBC Capital... Ultra Petroleum (UPL) upgraded to Outperform from Market Perform at Raymond James... Under Armour (UA) upgraded to Buy from Neutral at Sterne Agee... Hercules Technology (HTGC) upgraded to Buy from Hold at Sandler ONeill... Standard Pacific (SPF) upgraded to Outperform from Market Perform at Raymond James... Yelp (YELP) upgraded to Outperform from Perform at Oppenheimer... Netflix (NFLX) upgraded to Outperform from Perform at Oppenheimer... Pandora (P) upgraded to Outperform from Neutral at Wedbush.
09:34 EDTNFLXActive equity options trading on open
Subscribe for More Information
09:10 EDTMATOn The Fly: Pre-market Movers
HIGHER: Questcor (QCOR), up 27% after agreeing to be bought by Mallinckrodt (MNK) for cash, stock valued at $86.10 per Questcor share... Agios Pharmaceuticals (AGIO), up 25% after program shows "promising clinical activity" for advanced blood cancers, shares upgraded at JPMorgan... Vocus (VOCS), up 47% after agreeing to be acquired by GTCR for $446.5M, or $18.00 per share... Pandora (P), up 1.3% following upgrade at Wedbush. LOWER: MannKind (MNKD), down 13% after announcing FDA extension of PDUFA date for Afrezza... American Eagle (AEO), down 2.2% following downgrade at Cowen... Pfizer (PFE), down 2.8% after announcing data for palbociclib in metastatic breast cancer... Mattel (MAT), down 3% following downgrade at BMO Capital... WWE (WWE), down 1.2% after cautious mention in Barron's, company announcing WrestleMania 30 grossed $10.9M.
09:04 EDTMCKMcKesson announces results of Celesio takeover offer
Subscribe for More Information
08:09 EDTMRKAlnylam's McSwiggen patent upheld in European opposition proceedings
Subscribe for More Information
07:27 EDTMRKAmerican Association of Cancer Research to hold annual meeting
Subscribe for More Information
07:09 EDTNFLXNetflix upgraded to Outperform from Perform at Oppenheimer
Oppenheimer upgraded its rating on Netflix (NFLX) shares to Outperform with a $419 price target citing the recent pullback in shares. Opco sees an attractive risk/reward profile at current share levels.
06:41 EDTNFLXMicrosoft pushes for programming to rival Amazon, Netflix, Bloomberg says
Subscribe for More Information
06:04 EDTMATMattel downgraded to Underperform from Market Perform at BMO Capital
BMO Capital downgraded Mattel citing earnings risk from cyclical declines in Barbie and Hot Wheels, disappointing performance in Max Steel and Ever After High, and deteriorating sales in Monster High. The analyst sees continued deterioration in earnings given weak mature markets, challenges in emerging markets, and lack of sales leverage and cost savings opportunities. Price target lowered to $33 from 40.
April 6, 2014
14:21 EDTNFLXYahoo plans to acquire bigger budget TV programming, WSJ says
Subscribe for More Information
13:37 EDTMRKMerck presents findings on clinical outcomes following treatment with MK-3475
Subscribe for More Information
April 4, 2014
17:12 EDTNFLXMarket finishes mixed as Nasdaq sells off into weekend
Subscribe for More Information
16:30 EDTNFLXOn The Fly: Closing Wrap
Subscribe for More Information
16:00 EDTNFLXOptions Update; April 4, 2014
iPath S&P 500 VIX Short-Term Futures up 89c to 41.88. Option volume leaders: AAPL C P NFLX LNG BAC INTC TSLA TWTR according to Track Data.
10:10 EDTNFLXNetflix April volatility elevated as shares trend to nine-week low
Subscribe for More Information
09:52 EDTNFLXNetflix downtrend accelerates, levels to watch
Subscribe for More Information
09:36 EDTNFLXActive equity options trading on open
Active equity options trading on open according to Track Data: AAPL TSLA MU GNK AMZN FB GILD MA NFLX
08:07 EDTMRKMerck, Ferring announce collaboration with WHO
Merck and Ferring Pharmaceuticals announced their collaboration with the World Health Organization to advance a new, proprietary formulation of carbetocin, used to prevent excessive bleeding in women after childbirth, that is designed to be stable at room temperature, even in hot and tropical climates. Currently, oxytocin, the standard medicine administered for the prevention of excessive bleeding, is temperature-sensitive and requires sustained cold distribution and storage in hot climates. The WHO will conduct a multi-country clinical study to evaluate the effectiveness of room-temperature-stable carbetocin, as compared to oxytocin. The development of a medicine that can be stored at room temperature has the potential to significantly improve management of bleeding following childbirth in the many areas of the world where cold storage is difficult to achieve and maintain, and thereby help reduce maternal deaths in those areas. Starting this year, the study will take place in 12 countries around the world and enroll approximately 29,000 women. If the results of the study are positive, the organizations will work together with the aim of making the medicine available in developing countries that have a high burden of maternal mortality at an affordable and sustainable public-sector price.
1 | 2 | 3 | 4 | 5 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use